Viridian Therapeutics Inc (VRDN)
13.01
+0.23
(+1.80%)
USD |
NASDAQ |
Jun 28, 16:00
13.00
-0.01
(-0.08%)
After-Hours: 20:00
Viridian Therapeutics Total Liabilities (Quarterly): 47.85M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 47.85M |
| December 31, 2023 | 48.40M |
| September 30, 2023 | 45.18M |
| June 30, 2023 | 35.61M |
| March 31, 2023 | 36.09M |
| December 31, 2022 | 40.03M |
| September 30, 2022 | 31.57M |
| June 30, 2022 | 27.92M |
| March 31, 2022 | 16.52M |
| December 31, 2021 | 15.99M |
| September 30, 2021 | 16.61M |
| June 30, 2021 | 19.29M |
| March 31, 2021 | 16.83M |
| December 31, 2020 | 11.22M |
| September 30, 2020 | 11.79M |
| June 30, 2020 | 12.31M |
| March 31, 2020 | 12.05M |
| December 31, 2019 | 14.51M |
| September 30, 2019 | 15.64M |
| June 30, 2019 | 15.34M |
| March 31, 2019 | 13.99M |
| Date | Value |
|---|---|
| December 31, 2018 | 14.80M |
| September 30, 2018 | 15.84M |
| June 30, 2018 | 14.22M |
| March 31, 2018 | 14.29M |
| December 31, 2017 | 13.97M |
| September 30, 2017 | 8.096M |
| June 30, 2017 | 8.69M |
| March 31, 2017 | 9.80M |
| December 31, 2016 | 4.585M |
| September 30, 2016 | 2.855M |
| June 30, 2016 | 2.605M |
| March 31, 2016 | 2.457M |
| December 31, 2015 | 2.492M |
| September 30, 2015 | 2.164M |
| June 30, 2015 | 2.151M |
| March 31, 2015 | 2.598M |
| December 31, 2014 | 2.098M |
| September 30, 2014 | 1.995M |
| June 30, 2014 | 2.200M |
| March 31, 2014 | 1.870M |
| December 31, 2013 | 27.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.22M
Minimum
Dec 2020
48.40M
Maximum
Dec 2023
25.02M
Average
16.83M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 48.40M |
| Electromed Inc | 6.357M |
| Xtant Medical Holdings Inc | 46.25M |
| Asensus Surgical Inc | 27.79M |
| Myomo Inc | 5.621M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 630.38M |
| Shareholders Equity (Quarterly) | 582.53M |
| Debt to Equity Ratio | 0.0349 |
| Current Ratio | 23.99 |
| Net Debt Paydown Yield | -0.28% |